Soru

Zorluk: ZorPediatric Hematology and Oncology

An 88-year-old boy is evaluated on the pediatric ward for sudden onset of respiratory distress. He has a medical history significant for homozygous hemoglobin S disease. He was admitted 22 days ago for a severe vaso-occlusive pain episode affecting his bilateral lower extremities, which has been managed with intravenous hydration and morphine. Today, he developed a new-onset fever with a temperature of 39.2∘C39.2^\circ\text{C}, a respiratory rate of 32/min32/\text{min}, and sharp right-sided chest pain. Pulse oximetry shows an oxygen saturation of 87%87\% on room air. Physical examination reveals decreased breath sounds and crackles in the right lower lung field. Laboratory studies show that his hemoglobin level has dropped from a baseline of 8.2 g/dL8.2\text{ g/dL} to 6.1 g/dL6.1\text{ g/dL}, and his leukocyte count is 18,500/\muL18,500/\text{\mu L}. A chest radiograph demonstrates a new right lower lobe consolidation. Which of the following is the most appropriate next step in the management of this patient?

  1. Red blood cell transfusion and intravenous administration of a third-generation cephalosporin and a macrolideCevap
  2. B
    Administration of systemic corticosteroids, inhaled albuterol, and a viral respiratory panel
  3. C
    Intravenous administration of furosemide and strict fluid restriction
  4. D
    Empiric administration of intravenous vancomycin and piperacillin-tazobactam while withholding blood transfusion
  5. E
    Immediate transport to radiology for a computed tomography pulmonary angiography

Cevap

Red blood cell transfusion combined with intravenous administration of a third-generation cephalosporin and a macrolide.
The patient's presentation of fever, chest pain, tachypnea, hypoxia, and a new pulmonary infiltrate in the setting of homozygous sickle cell anemia is diagnostic of acute chest syndrome (ACS). ACS is a medical emergency characterized by a vicious cycle of hypoxia leading to further red blood cell sickling and pulmonary infarction. The most appropriate initial management includes supplemental oxygen, pain control, empiric antibiotics covering both typical and atypical respiratory pathogens (such as a third-generation cephalosporin and a macrolide), and a red blood cell transfusion. Transfusion (simple or exchange, depending on severity) is the definitive therapy to increase the oxygen-carrying capacity and decrease the percentage of hemoglobin S, thereby breaking the sickling cycle.

Adım Adım Çözüm

1
Identify the primary complication based on the clinical presentation.
The patient has fever, hypoxia, chest pain, and a new pulmonary infiltrate on chest X-ray in the context of sickle cell anemia, which confirms the diagnosis of Acute Chest Syndrome (ACS).
Establishing the correct diagnosis is essential to distinguish ACS from isolated pneumonia, asthma, or fluid overload.
2
Determine the underlying pathophysiology requiring urgent intervention.
Hypoxia, infection, and inflammation are inducing further hemoglobin S polymerization, leading to worsening pulmonary infarction and a rapidly dropping hemoglobin level.
Understanding the sickling cycle highlights the critical need to not just treat the infection, but to directly improve oxygen-carrying capacity and dilute the sickle hemoglobin.
3
Select the comprehensive treatment bundle.
The patient urgently requires a red blood cell transfusion to reduce the HbS fraction, alongside atypical and typical bacterial coverage (cephalosporin and macrolide).
RBC transfusion definitively breaks the cycle of sickling, while targeted antibiotics treat the most common infectious triggers of ACS.

Anahtar Kavram

Diagnosis and management of Acute Chest Syndrome in pediatric patients with sickle cell disease.
Tahmini Süre:1m 30s
Bu soruyu puanla